Search

Your search keyword '"Masiero, M."' showing total 10 results
Start Over Author "Masiero, M." Publisher elsevier bv
10 results on '"Masiero, M."'

1. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

Author

Vaz-Luis, I., primary, Masiero, M., additional, Cavaletti, G., additional, Cervantes, A., additional, Chlebowski, R.T., additional, Curigliano, G., additional, Felip, E., additional, Ferreira, A.R., additional, Ganz, P.A., additional, Hegarty, J., additional, Jeon, J., additional, Johansen, C., additional, Joly, F., additional, Jordan, K., additional, Koczwara, B., additional, Lagergren, P., additional, Lambertini, M., additional, Lenihan, D., additional, Linardou, H., additional, Loprinzi, C., additional, Partridge, A.H., additional, Rauh, S., additional, Steindorf, K., additional, van der Graaf, W., additional, van de Poll-Franse, L., additional, Pentheroudakis, G., additional, Peters, S., additional, and Pravettoni, G., additional

Published
2022
Full Text
View/download PDF

3. 1432P Incorporating psycho-social factors in cancer treatment adverse events studies

Author

Casini, C., primary, Monzani, D., additional, Masiero, M., additional, Mazzocco, K., additional, Grasso, R., additional, Fotiadis, D., additional, Memos, N., additional, Keramida, K., additional, Curigliano, G., additional, Cipolla, C., additional, Cardinale, D., additional, Papakonstantinou, A., additional, Constantinidou, A., additional, Conti, C., additional, and Pravettoni, G., additional

Published
2022
Full Text
View/download PDF

4. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

Author

Vaz-Luis, I, Masiero, M, Cavaletti, G, Cervantes, A, Chlebowski, R, Curigliano, G, Felip, E, Ferreira, A, Ganz, P, Hegarty, J, Jeon, J, Johansen, C, Joly, F, Jordan, K, Koczwara, B, Lagergren, P, Lambertini, M, Lenihan, D, Linardou, H, Loprinzi, C, Partridge, A, Rauh, S, Steindorf, K, van der Graaf, W, van de Poll-Franse, L, Pentheroudakis, G, Peters, S, Pravettoni, G, Chlebowski, R T, Ferreira, A R, Ganz, P A, Partridge, A H, Vaz-Luis, I, Masiero, M, Cavaletti, G, Cervantes, A, Chlebowski, R, Curigliano, G, Felip, E, Ferreira, A, Ganz, P, Hegarty, J, Jeon, J, Johansen, C, Joly, F, Jordan, K, Koczwara, B, Lagergren, P, Lambertini, M, Lenihan, D, Linardou, H, Loprinzi, C, Partridge, A, Rauh, S, Steindorf, K, van der Graaf, W, van de Poll-Franse, L, Pentheroudakis, G, Peters, S, Pravettoni, G, Chlebowski, R T, Ferreira, A R, Ganz, P A, and Partridge, A H

Abstract

Background: The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship. Design and methods: Herein, we reflected on the different components of survivorship care, existing models and priorities, in order to facilitate the promotion of high-quality European survivorship care and research. Results: We identified five main components of survivorship care: (i) physical effects of cancer and chronic medical conditions; (ii) psychological effects of cancer; (iii) social, work and financial effects of cancer; (iv) surveillance for recurrences and second cancers; and (v) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High-quality care should be expedited by the generation of: (i) focused and shared European recommendations, (ii) creation of tools to facilitate implementation of coordinated care and (iii) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers, patients and caregivers. The following patient-centered survivorship research areas were highlighted: (i) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to (a) understand the resources, needs and preferences of patients with cancer, and (b) understand biological determinants of survivorship issues, and (ii) develop innovative effective interventions focused on the main components of survivorship care. Conclusions: The European Society for Medical Oncology (ESMO) can actively contribute in the efforts of the oncology community toward (a

Published
2022

6. 1728 Sexual problems in cancer patients: An integrated approach to overcome taboos and resistance

Author

Milani, A., primary, Mazzocco, K., additional, Masiero, M., additional, Tasca, N., additional, Passoni, C., additional, Di Leo, M., additional, Sbriglia, A., additional, Pari, C., additional, Gandini, A., additional, Chiara, C., additional, Sinisi, A., additional, Peschechera, I., additional, Liptrott, S.J., additional, Lacapra, S., additional, Misurelli, E., additional, Magon, G., additional, and Pravettoni, G., additional

Published
2015
Full Text
View/download PDF

7. 1720 How many research nurses for how many clinical trials in an oncology setting? Definition of the Nursing Time Required by Clinical Trial - Assessment Tool (NTRCT-AT)

Author

Milani, A., primary, Stucchi, S., additional, Saiani, L., additional, Pravettoni, G., additional, Di Leo, M., additional, Passoni, C., additional, Profeta, T., additional, Gandini, A., additional, Ciccarelli, C., additional, Paria, C., additional, Sbriglia, A., additional, Liptrott, S.J., additional, Peschechera, I., additional, Tasca, N., additional, Sinisi, A., additional, Mazzocco, K., additional, Masiero, M., additional, and Magon, G., additional

Published
2015
Full Text
View/download PDF

10. Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months

Author

Ketti Mazzocco, C Jemos, Marianna Masiero, Gabriella Pravettoni, Claudio Lucchiari, Raffaella Bertolotti, Patrick Maisonneuve, Stefania Spina, Giulia Veronesi, Emanuela Omodeo Salè, Lucchiari, C., Masiero, M., Mazzocco, K., Veronesi, G., Maisonneuve, P., Jemos, C., Omodeo Sale, E., Spina, S., Bertolotti, R., and Pravettoni, G.

Subjects
Lung Diseases, Male, Nicotine, Nicotine-free e-cigarette, medicine.medical_specialty, Time Factors, Health Status, medicine.medical_treatment, Medicine (miscellaneous), Catarrh, Electronic Nicotine Delivery Systems, Smoking cessation, Toxicology, Placebo, law.invention, E-cigarette, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Humans, Smoking Reduction, Early Detection of Cancer, Aged, Motivation, business.industry, Middle Aged, medicine.disease, Tobacco Use Cessation Devices, Clinical trial, Psychiatry and Mental health, Clinical Psychology, Pulmonary health, Female, Smoking Cessation, business, Lung cancer screening, medicine.drug
Abstract

Introduction: Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods: The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results: Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results